Clinical Trials Directory

Trials / Completed

CompletedNCT05743192

Discontinuation of Antibiotic Susceptibility Testing on Enterococcus Faecalis Positive Urine Cultures in Hospitalized Patients: an Impact on Antibiotic Prescriptions? (FaecaCible)

Discontinuation of Antibiotic Susceptibility Testing on Monobacterial Enterococcus Faecalis Positive Urine Cultures: an Impact on Antibiotic Prescriptions?

Status
Completed
Phase
Study type
Observational
Enrollment
217 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to evaluate the impact of not reporting antibiotic susceptibility tests on antibiotic consumption for Enterococcus faecalis positive urine cultures in adult hospitalized patients. The secondary objectives are to evaluate the impact of this intervention on antibiotic prescription rates as well as on antibiotic consumption according to: patient gender, type of antibiotic therapy (probabilistic/documented) and diagnosis (urinary tract infection or colonization). It is hypothesized that antibiotic consumption is lower after the application of the absence of antibiotic susceptibility reporting compared to before.

Conditions

Interventions

TypeNameDescription
OTHERStop performing an antibiotic susceptibility testIntervention = Stop performing an antibiotic susceptibility test for enterococcus faecalis in urine cultures. It defines two groups : one before and one after the intervention

Timeline

Start date
2023-02-15
Primary completion
2023-06-08
Completion
2023-06-08
First posted
2023-02-24
Last updated
2023-06-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05743192. Inclusion in this directory is not an endorsement.